SOPHARMA (SPH): Sales revenues for March 2018 - raport 14

UNI - EN REPORT No

14

/

2018

UNI - EN REPORT No14/2018

Sofia, Bulgaria, April 5, 2018 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for March 2018 the Company recorded a decrease of sales revenues of 10% compared to the same month of 2017, including 1% increase of domestic sales and a decrease of 19% of export sales.

For the first three months of this year, revenues from sales of products decreased by 3% compared to the same period of 2017, including 0.5% increase of domestic sales and 6% decrease of export sales.

Załączniki